Anti-Human RNH1 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22355; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing the Anti-Human RNH1 Polyclonal Antibody – your go-to solution for reliable and accurate RNA hybridization experiments.
This highly specific antibody is designed to target and bind to the RNH1 protein, also known as ribonuclease inhibitor 1, which plays a crucial role in regulating the activity of ribonucleases – enzymes responsible for breaking down RNA molecules. By binding to RNH1, this antibody effectively inhibits the activity of ribonucleases, allowing for more precise and controlled RNA hybridization experiments.
Our Anti-Human RNH1 Polyclonal Antibody has a wide range of applications in the field of biotechnology. It is commonly used in gene expression studies, as well as in the detection and analysis of RNA-protein interactions. Additionally, it has been shown to be effective in RNA interference (RNAi) experiments, where it helps to protect RNA molecules from degradation.
This antibody has been extensively tested and validated for use in various experimental techniques, including western blotting, immunofluorescence, and immunohistochemistry. Its high specificity and sensitivity make it a reliable tool for researchers looking to study the role of RNH1 in various biological processes.
One of the key advantages of using our Anti-Human RNH1 Polyclonal Antibody is its ability to work with a wide range of sample types, including tissue lysates, cell lysates, and purified proteins. Its versatility and ease of use make it a valuable asset in any laboratory setting.
In conclusion, the Anti-Human RNH1 Polyclonal Antibody is a powerful tool for studying RNA hybridization and related processes. Its high specificity, wide range of applications, and proven effectiveness make it a top choice for researchers in the biotech industry. Trust in our product to deliver accurate and reliable results for all your RNH1-related experiments.
ProteoGenix catalogue number ARO-A22355. For research use only.
Target: Ribonuclease inhibitor, Placental ribonuclease inhibitor, Placental RNase inhibitor, Ribonuclease/angiogenin inhibitor 1, RAI, RNH1, PRI, RNH; Clonality: Polyclonal Antibody; Reactivity: Human; Applications: ELISA, IHC, WB.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
